Atlas FDA

Predicate Research Report · generated 2026-08-21 · Print / save as PDF · Save to account

DPB — Predicate Candidate Screening

10 FDA 510(k) clearances under this product code; the 50 most recent screened below.

21 daysmedian FDA review time
125 days90th percentile
10clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K853021OPTIMATE DIGOXIN TESTMiles Laboratories, Inc.1985-08-07200
K823014DIGOXIN KITPcl-Ria, Inc.1982-11-01190
K821811125I DIGOXIN RADIOIMMUNOASSAY KITCambridge Medical Technology1982-07-02140
K820274DIGOXIN RADIOIMMUNOASSAYAmerican Diagnostic Corp.1982-02-23210
K792153DIGOXIN RADIOIMMUNOASSAY SYSTEMRadioimmunoassay, Inc.1979-11-13180
K790602RIA, DIGNXIN-125-IEndocrine-Metabolic Center1979-07-301250
K790540RIA TEST KIT, CENTRIA DIGOXINVentrex Laboratories, Inc.1979-04-23340
K772306125I DIGOXIN TEST SETWien Laboratories, Inc.1977-12-2270
K771525125 I DIGOXIN RIA KITDiagnostic Products Corp.1977-10-14670
K760883DIGI-TAB-RIA DIGOXIN RADIOMMUNOASSAYNuclear Medical Laboratories, Inc.1976-11-19290

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda